Management and Supervision
In compliance with the German Stock Corporation Act (AktG), Wacker Chemie AG has a two-tier management system, comprising an Executive Board and Supervisory Board. The Executive Board has four members.
Wacker Chemie AG is the parent company and thus determines the Group’s strategy, overall management, resource allocation, funding, and communications with key target groups (especially with the capital market and shareholders).
Executive Board Responsibilities (as of May 2021)
Dr. Christian Hartel
President & CEO
WACKER BIOSOLUTIONS, WACKER POLYSILICON, Corporate Development, Corporate Communications, Corporate Auditing, Legal, Compliance, Retirement Benefits
Dr. Tobias Ohler
Corporate Accounting and Tax, Corporate Controlling, Corporate Finance and Insurance, Investor Relations, Information Technology, Procurement & Logistics
Region: The Americas
Auguste Willems
WACKER SILICONES, Sales and Distribution, Site Management, Research & Development, Corporate Security, Environment / Health / Safety, Product Stewardship
Regions: Europe, Middle East
Angela Wörl
WACKER POLYMERS, Human Resources (Personnel Director), Executive Personnel, Intellectual Property, Corporate Engineering
Region: Asia
Executive Board and Supervisory Board in the 2019/2020 Reporting Period
Seppel Kraus retired from Wacker Chemie AG’s Supervisory Board, stepping down effective June 30, 2019. A new Supervisory Board member, Beate Rohrig, was appointed as employee representative at the Executive Board’s request by order of the District Court of Munich dated July 18, 2019.
Konrad Kammergruber retired from Wacker Chemie AG’s Supervisory Board, stepping down effective September 30, 2020. Dr. Birgit Schwab, who had already been elected as an alternate member, replaced him as an employee representative on the Supervisory Board. With effect from December 31, 2020, Jörg Kammermann, former district chairman of the IG BCE labor union for the Altötting district, stepped down from Wacker Chemie AG’s Supervisory Board. Markus Hautmann, new district chairman of IG BCE Altötting, was appointed as his successor effective January 1, 2021.
There were no changes to the composition of Wacker Chemie AG’s Executive Board in 2019 or 2020. At its meeting on March 11, 2020, the Supervisory Board renewed Dr. Tobias Ohler’s contract for five years until 2025.
At another meeting on December 9, 2020, it made key personnel decisions. Dr. Rudolf Staudigl, President & CEO of the Executive Board, was to retire at the end of the Annual Shareholders’ Meeting on May 12, 2021. The Supervisory Board appointed Dr. Christian Hartel to succeed him as President & CEO of the Executive Board as of that date. At the same time, Angela Wörl was to join the Executive Board as Personnel Director.